Literature DB >> 26095253

Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.

Si Ming Man1, Qifan Zhu2, Liqin Zhu3, Zhiping Liu4, Rajendra Karki1, Ankit Malik1, Deepika Sharma1, Liyuan Li3, R K Subbarao Malireddi1, Prajwal Gurung1, Geoffrey Neale5, Scott R Olsen5, Robert A Carter6, Daniel J McGoldrick6, Gang Wu6, David Finkelstein6, Peter Vogel7, Richard J Gilbertson8, Thirumala-Devi Kanneganti9.   

Abstract

Colorectal cancer is a leading cause of cancer-related deaths. Mutations in the innate immune sensor AIM2 are frequently identified in patients with colorectal cancer, but how AIM2 modulates colonic tumorigenesis is unknown. Here, we found that Aim2-deficient mice were hypersusceptible to colonic tumor development. Production of inflammasome-associated cytokines and other inflammatory mediators was largely intact in Aim2-deficient mice; however, intestinal stem cells were prone to uncontrolled proliferation. Aberrant Wnt signaling expanded a population of tumor-initiating stem cells in the absence of AIM2. Susceptibility of Aim2-deficient mice to colorectal tumorigenesis was enhanced by a dysbiotic gut microbiota, which was reduced by reciprocal exchange of gut microbiota with healthy wild-type mice. These findings uncover a synergy between a specific host genetic factor and gut microbiota in determining the susceptibility to colorectal cancer. Therapeutic modulation of AIM2 expression and microbiota has the potential to prevent colorectal cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26095253      PMCID: PMC4491002          DOI: 10.1016/j.cell.2015.06.001

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  51 in total

Review 1.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

2.  Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis.

Authors:  Xinyang Song; Hanchao Gao; Yingying Lin; Yikun Yao; Shu Zhu; Jingjing Wang; Yan Liu; Xiaomin Yao; Guangxun Meng; Nan Shen; Yufang Shi; Yoichiro Iwakura; Youcun Qian
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

3.  The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.

Authors:  Stefan M Woerner; Matthias Kloor; Yvette Schwitalle; Hanni Youmans; Magnus von Knebel Doeberitz; Johannes Gebert; Susanne Dihlmann
Journal:  Genes Chromosomes Cancer       Date:  2007-12       Impact factor: 5.006

4.  Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.

Authors:  Susanne Dihlmann; Sha Tao; Fabian Echterdiek; Esther Herpel; Lina Jansen; Jenny Chang-Claude; Hermann Brenner; Michael Hoffmeister; Matthias Kloor
Journal:  Int J Cancer       Date:  2014-04-28       Impact factor: 7.396

5.  Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation.

Authors:  Dorine Bonte; Charlotta Lindvall; Hongyu Liu; Karl Dykema; Kyle Furge; Michael Weinreich
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

6.  Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

Authors:  Tomohiro Watanabe; Naoki Asano; Peter J Murray; Keiko Ozato; Prafullakumar Tailor; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation.

Authors:  Qifan Zhu; Si Ming Man; Prajwal Gurung; Zhiping Liu; Peter Vogel; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

8.  The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection.

Authors:  Si Ming Man; Rajendra Karki; R K Subbarao Malireddi; Geoffrey Neale; Peter Vogel; Masahiro Yamamoto; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2015-03-16       Impact factor: 25.606

9.  Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida.

Authors:  Etienne Meunier; Pierre Wallet; Roland F Dreier; Stéphanie Costanzo; Leonie Anton; Sebastian Rühl; Sébastien Dussurgey; Mathias S Dick; Anne Kistner; Mélanie Rigard; Daniel Degrandi; Klaus Pfeffer; Masahiro Yamamoto; Thomas Henry; Petr Broz
Journal:  Nat Immunol       Date:  2015-03-16       Impact factor: 25.606

10.  A comprehensive look at transcription factor gene expression changes in colorectal adenomas.

Authors:  Janine Vonlanthen; Michal J Okoniewski; Mirco Menigatti; Elisa Cattaneo; Daniela Pellegrini-Ochsner; Ritva Haider; Josef Jiricny; Teresa Staiano; Federico Buffoli; Giancarlo Marra
Journal:  BMC Cancer       Date:  2014-01-29       Impact factor: 4.430

View more
  133 in total

Review 1.  AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity.

Authors:  Si Ming Man; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2015-12-28       Impact factor: 5.532

2.  Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer.

Authors:  Rajendra Karki; Bhesh Raj Sharma; Ein Lee; Balaji Banoth; R K Subbarao Malireddi; Parimal Samir; Shraddha Tuladhar; Harisankeerth Mummareddy; Amanda R Burton; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  JCI Insight       Date:  2020-06-18

Review 3.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

Review 4.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

5.  Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation.

Authors:  Qiaoshi Lian; Jun Xu; Shanshan Yan; Min Huang; Honghua Ding; Xiaoyu Sun; Aiwei Bi; Jian Ding; Bing Sun; Meiyu Geng
Journal:  Cell Res       Date:  2017-04-14       Impact factor: 25.617

Review 6.  Inflammasomes and intestinal inflammation.

Authors:  N Zmora; M Levy; M Pevsner-Fishcer; E Elinav
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

Review 7.  The microbiome and innate immunity.

Authors:  Christoph A Thaiss; Niv Zmora; Maayan Levy; Eran Elinav
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

Review 8.  Inflammasomes in Myeloid Cells: Warriors Within.

Authors:  Sushmita Jha; W June Brickey; Jenny Pan-Yun Ting
Journal:  Microbiol Spectr       Date:  2017-01

Review 9.  The Role of the Gut Microbiome in Colorectal Cancer.

Authors:  Grace Y Chen
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

Review 10.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.